Innovative Market Access and Product Life Cycle Solutions for Life Sciences with AscellaHealth
Michael Baldzicki, Chief Brand Officer at AscellaHealth, a global specialty pharmacy and healthcare solutions company joins eHealth Radio and the Healthcare and Pharmaceutical Information Channels to talk about the company’s comprehensive suite of Specialty Pharmacy services for pharmaceutical/biotech manufacturers.
Can you give our listeners information on your background and role with AscellaHealth?
Please describe the AscellaHealth business model and how the company serves life sciences in the specialty pharmacy and healthcare industry.
AscellaHealth has an exciting new strategic alliance with Optime Care. Can you tell our listeners what this partnership means for others in the industry?
AscellaHealth recently came out with some expanded services. Can you explain these new offerings and their benefits for key market segments that AscellaHealth serves?
In the current healthcare environment, it seems people are lacking customizable options. Can you speak to the flexibility of AscellaHealth’s solutions and how this ultimately serves to enhance outcomes of branded products?
As chief brand officer for AscellaHealth, Mike ensures the success of the widest variety of strategic projects across departmental segments, and other business development initiatives that cultivate opportunities that affect client segments.
With more than 21+ years of specialty pharmacy, pharmaceutical and biotech industry experience, including roles in national and regional managed markets, specialty supply channels, sales management and specialty brand management. Mike offers strategic insight into specialty pharmacy trends, distribution, contracting, reimbursement, and the application of health outcomes and economic evidence to prove value proposition. He is a recognized leader in the specialty pharmaceutical market for developing and implementing key payer and specialty pharmacy agreements that result in documented savings for specialty market segments.
Mike is active in the biotech community and is an advisor/faculty member of the Academy of Managed Care Pharmacy (AMCP) for Specialty Pharmacy Advisory Group & Biosimilars Partnership Forum, NCPDP Specialty Pharmacy Stakeholder Action Group, Faulty Board Member of the American Journal of Managed Care (AJMC) Specialty Pharmacy for ACOs and was 2014 Editorial Board Member for Specialty Pharmacy Times.
He has published abstracts and articles surrounding plasma-based infusion therapy, and managed markets and specialty pharmacy. He has spoken at a variety of seminars and WebEx’s within specialty groups and other industry related settings.
Mike earned a Bachelor of Arts in Business Management and a Certificate in Clinical Research Compliance and Management (CRCM). He has completed programs in leadership development at Harvard University, Brooks Group, Miller Heiman Account Management and MD Anderson Center Cancer Courses.